Walgreens Boots Alliance, Inc. and Wave Life Sciences Ltd.: SG&A Spending Patterns Compared

SG&A Spending: Walgreens vs. Wave Life Sciences

__timestampWalgreens Boots Alliance, Inc.Wave Life Sciences Ltd.
Wednesday, January 1, 2014179920000002999000
Thursday, January 1, 20152240000000010393000
Friday, January 1, 20162391000000015994000
Sunday, January 1, 20172381300000026975000
Monday, January 1, 20182469400000039509000
Tuesday, January 1, 20192355700000048869000
Wednesday, January 1, 20202543600000042510000
Friday, January 1, 20212458600000046105000
Saturday, January 1, 20222729500000050513000
Sunday, January 1, 20233420500000051292000
Monday, January 1, 202428113000000
Loading chart...

Cracking the code

SG&A Spending Patterns: Walgreens Boots Alliance vs. Wave Life Sciences

In the ever-evolving landscape of corporate finance, understanding the spending patterns of industry giants and emerging players is crucial. Walgreens Boots Alliance, Inc., a stalwart in the retail pharmacy sector, has consistently demonstrated robust SG&A (Selling, General, and Administrative) expenses over the past decade. From 2014 to 2023, Walgreens' SG&A expenses have grown by approximately 43%, peaking in 2023. This growth reflects strategic investments in operations and customer engagement.

Conversely, Wave Life Sciences Ltd., a burgeoning biotech firm, showcases a different trajectory. Despite a smaller scale, Wave's SG&A expenses have surged by over 1,600% from 2014 to 2023, highlighting its aggressive expansion and R&D focus. However, data for 2024 remains unavailable, indicating potential shifts in strategy or reporting.

This comparative analysis underscores the diverse financial strategies employed by established and emerging companies in navigating their respective markets.

Published by
U.S. Securities and Exchange Commission

Source link
sec.gov

Date published
17 Jan 2025